SET and Alzheimer disease: CK2 co-localizes with NFTs (Masliah et al., 1992) while SET mediates the formation of NFTs consisting of hyperphosphorylated tau (Arif et al., 2014), indicating that there might be a cross-talk between CK2 and SET in AD pathogenesis.